Not only that CP. From the Opdivo trial we know there were only 5 censored patients within the first 15 months, a number I find very small or insignificant. After the 15th month there was a total of about 17%... rather uniformly distributed amongst the 15th mont till the end. So not taking into account censored patients would not make much of difference to the numbers you estimated